Citius Pharmaceuticals, Inc. (CTXR) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Citius Pharmaceuticals, Inc. on June 7, 2021. The company is incorporated in Nevada and its common stock and warrants trade on The Nasdaq Capital Market under the symbols CTXR and CTXRW, respectively.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report is limited to a corporate governance event.
Material Changes
Under Item 8.01 (Other Events), the company announced it has been added to the Russell 2000 Index following the annual reconstitution of the Russell US Indexes. This inclusion is effective at the opening of U.S. equity markets on June 28, 2021.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The sole purpose of the report is to disclose the index inclusion event.
Investor Verification Checklist
- Verify the effective date of the Russell 2000 Index inclusion (June 28, 2021).
- Review the attached press release (Exhibit 99.1) for details on the reconstitution process.
- Confirm the impact of index inclusion on the company's trading volume and institutional ownership.